Miller D, Gruenberg P, Miller R, Bergamini M V
Arch Ophthalmol. 1981 Apr;99(4):681-2. doi: 10.1001/archopht.1981.03930010681016.
Flurbiprofen is a nonsteroidal anti-inflammatory (NSAI) agent currently undergoing clinical investigation. Anti-inflammatory steroids have long been known to delay the healing of corneal stromal wounds. This was designed to compare the effects of equipotent anti-inflammatory doses of flurbiprofen and of prednisolone acetate on the inflammation and the healing (as measured by the wound bursting pressure) or 4-mm through-and-through incisions treated four times a day for ten postoperative days. The results suggest that flurbiprofen and prednisolone are not different in their effect on both postoperative inflammation and postoperative wound healing. Since NSAI agents and steroids inhibit prostaglandin formation at different enzymatic steps, it is possible that prostaglandins not only are responsible for postoperative inflammation but also are required for postoperative wound healing.
氟比洛芬是一种目前正在进行临床研究的非甾体抗炎药(NSAI)。长期以来,人们一直知道抗炎类固醇会延迟角膜基质伤口的愈合。本研究旨在比较等效抗炎剂量的氟比洛芬和醋酸泼尼松龙对炎症和愈合的影响(通过伤口破裂压力测量),对4毫米全层切口术后每天治疗4次,持续10天。结果表明,氟比洛芬和泼尼松龙对术后炎症和术后伤口愈合的影响没有差异。由于NSAI药物和类固醇在不同的酶促步骤抑制前列腺素的形成,因此前列腺素不仅可能导致术后炎症,而且可能是术后伤口愈合所必需的。